Lv31
276 积分 2022-10-31 加入
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing
1小时前
求助中
Recommendations for the Diagnosis of Extramedullary Multiple Myeloma
20天前
已完结
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma
1个月前
已完结
Primary central nervous system marginal zone lymphoma
2个月前
已完结
Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma
2个月前
已完结
CD20 xCD3 bispecific antibodies for large B cell lymphoma: latest updates from 2024 ASH annual meeting
2个月前
已关闭
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
2个月前
已完结
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
2个月前
已完结
Slit-Lamp Biomicroscope
2个月前
已关闭
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
